Minneapolis, MN, United States of America

Nathan Arian Abel

This inventor holds 1 USPTO granted patent. Top assignee: Pari Pharma Gmbh. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathan Arian Abel: Innovator in Nebulizer Technology

Introduction

Nathan Arian Abel is an accomplished inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical technology, particularly in the area of nebulizer devices. His innovative work focuses on improving patient compliance and monitoring during nebulized medication treatments.

Latest Patents

Nathan holds a patent for a nebulizer monitoring device, system, and method. This invention is designed to monitor the use of nebulized medication, which is crucial for patients undergoing treatment for chronic obstructive pulmonary disease (COPD). The device tracks important parameters such as flow, humidity, and acceleration, providing valuable data regarding the quantity and quality of nebulizer use. He has 1 patent to his name.

Career Highlights

Nathan Arian Abel is currently employed at Pari Pharma GmbH, where he continues to develop innovative solutions in the medical device sector. His work is instrumental in enhancing the effectiveness of nebulizer treatments and ensuring better health outcomes for patients.

Collaborations

Nathan collaborates with talented professionals in his field, including Michael Segal and Spencer Brown. Their combined expertise contributes to the advancement of nebulizer technology and patient care.

Conclusion

Nathan Arian Abel is a notable inventor whose work in nebulizer technology is making a difference in the lives of patients with respiratory conditions. His dedication to innovation and collaboration in the medical field is commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…